investigation – Pharma GMP

How to Handle Deviations and Outliers in Hold Time Studies

digi — Wed, 26 Nov 2025 04:03:04 +0000

How to Handle Deviations and Outliers in Hold Time Studies Effective Management of Deviations and Outliers in Hold Time Studies for Bulk Product Hold time studies for bulk product are essential components of pharmaceutical Good Manufacturing Practice (GMP) compliance. They ensure that the quality attributes of bulk materials remain within specification when stored under defined...

Deviation Investigation Workflow for Manufacturing-Related Issues

digi — Wed, 26 Nov 2025 02:24:04 +0000

Deviation Investigation Workflow for Manufacturing-Related Issues Step-by-Step Guide to Batch Manufacturing Deviation Handling In the pharmaceutical industry, effective batch manufacturing deviation handling is essential for maintaining product quality, compliance with Good Manufacturing Practices (GMP), and ensuring patient safety. Deviations related to manufacturing processes can range from minor anomalies to critical events potentially impacting product integrity....

SOP for Handling Market Complaints and Product Quality Inquiries

digi — Tue, 25 Nov 2025 23:57:04 +0000

SOP for Handling Market Complaints and Product Quality Inquiries Step-by-Step Guide to Establishing a Complaint Handling SOP for Pharmaceutical Market Complaints Pharmaceutical companies must maintain robust processes for addressing market complaints and product quality inquiries. A complaint handling SOP ensures consistency, regulatory compliance, and effective resolution, safeguarding patient safety and company reputation. This comprehensive guide...

SOP for Handling Out-of-Specification (OOS) Results in QC Laboratory

digi — Tue, 25 Nov 2025 22:24:04 +0000

SOP for Handling Out-of-Specification (OOS) Results in QC Laboratory Comprehensive Step-by-Step Guide to SOP for Handling Out-of-Specification (OOS) Results in QC Laboratory An Out-of-Specification (OOS) result is a critical finding in Quality Control (QC) laboratories that demands immediate, methodical, and regulatory-aligned investigation. This article provides a detailed step-by-step tutorial guide to creating and executing an...

Handling Lost, Damaged or Missing GMP Records: Investigation Playbook

digi — Tue, 25 Nov 2025 18:30:04 +0000

Handling Lost, Damaged or Missing GMP Records: Investigation Playbook Step-by-Step Guide for Conducting a Missing GMP Records Investigation Good Manufacturing Practice (GMP) compliance depends heavily on accurate, comprehensive, and retrievable documentation. When GMP records go missing, are damaged, or lost, it threatens the integrity of quality systems and regulatory compliance. Effective handling of such incidents...

Case Studies: In-Process Testing Failures That Led to Batch Rejection

digi — Tue, 25 Nov 2025 15:27:04 +0000

Case Studies: In-Process Testing Failures That Led to Batch Rejection Case Studies of In-Process Testing Failures and Resulting Batch Rejections in Pharmaceutical Manufacturing In process controls in pharmaceutical manufacturing are essential tools designed to monitor and ensure product quality during various stages of production. These controls help detect deviations and non-conformities early, allowing for corrective...

How to Set Yield Tolerances and Investigate Yield Deviations

digi — Tue, 25 Nov 2025 15:21:04 +0000

How to Set Yield Tolerances and Investigate Yield Deviations Step-by-Step Guide to Setting Yield Tolerances and Investigating Yield Deviations in Pharmaceutical GMP The pharmaceutical manufacturing industry is highly regulated to ensure product quality, patient safety, and regulatory compliance. One critical aspect of pharmaceutical Good Manufacturing Practice (GMP) is yield management, which includes yield calculations and...

Managing Environmental Monitoring Deviations and Out-of-Limit Results

digi — Tue, 25 Nov 2025 13:12:04 +0000

Managing Environmental Monitoring Deviations and Out-of-Limit Results Comprehensive Step-by-Step Guide to Managing Environmental Monitoring Deviations and Out-of-Limit Results Environmental monitoring is a cornerstone of pharmaceutical quality control, critical for ensuring sterile and non-sterile manufacturing environments remain within acceptable microbiological and particulate limits. An effective environmental monitoring program for QC laboratories supports compliance with regulatory expectations,...

Dealing with Sterility Test Failures: Investigation and CAPA

digi — Tue, 25 Nov 2025 12:54:04 +0000

Dealing with Sterility Test Failures: Investigation and CAPA Step-by-Step Guide to Handling Sterility Test Failures in QC Laboratory The integrity of sterility testing in QC laboratory environments is critical for ensuring final pharmaceutical product safety and compliance with regulatory standards. Sterility test failures pose significant risks to product release and patient safety, demanding robust and...

OOT Investigation Workflow: Differentiating Noise from True Signals

digi — Tue, 25 Nov 2025 11:30:04 +0000

OOT Investigation Workflow: Differentiating Noise from True Signals Step-by-Step Tutorial: Investigating Out of Trend (OOT) Results in QC Laboratories Out of trend (OOT) results in QC testing can pose significant challenges in pharmaceutical manufacturing, potentially impacting product quality and regulatory compliance. Distinguishing between random variability (noise) and true signals indicative of an underlying problem is...